Prescription drugs can be expensive, especially for patients who are uninsured or have limited financial resources. Otsuka Patient Assistance Foundation (OPAF) aims to provide eligible patients with no-cost support for specific prescribed medications. In this article, we will explore how OPAF can help you save on your prescription medications and guide you through the process of accessing their services.
Understanding Otsuka Patient Assistance Foundation (OPAF)
OPAF is a foundation that offers financial assistance to eligible patients for specific prescribed medications. They work closely with healthcare professionals and aim to ensure that their patient assistance program gives patients access to the medications they need, regardless of their financial situation. OPAF provides support for specific medications.
To access OPAF’s services, it is essential to review the full prescribing information for the medications you are prescribed. You can find this information on the official U.S. FDA website or consult with your healthcare prescriber. It is crucial to be aware of any boxed warnings or specific instructions related to your prescribed medications.
Eligibility for OPAF support
To be eligible for OPAF support, you need to meet certain criteria. While OPAF does not determine eligibility based on U.S. citizenship, you must have a U.S. home address. Acceptable documentation for your U.S. home address includes a mortgage statement, rental agreement, utility bills, or a state driver’s license or ID with your current home address.
Additionally, OPAF requires proof of income for all members of your household who file a tax return. Acceptable documentation includes federal income tax returns, W-2 forms, 1099-MISC forms, pay stubs, social security award letters, disability income information, unemployment benefits letters, or a letter from your employer on company letterhead. If you cannot provide any of these documents, you may request an income attestation letter from your healthcare prescriber.
How to apply for OPAF support
Applying for OPAF support is a straightforward process. You can begin the application process once you have gathered all the necessary documentation. OPAF offers a secure messaging platform, which allows you to communicate directly with a Patient Access Advocate without having to pick up the phone. This platform ensures patient privacy and is HIPAA-compliant.
To start the process, click on the button or envelope provided on the OPAF website. The system will prompt you to enter your email address as a “New to SecureContact.” A verification email will be sent to the email address you provided. Open this email and click on the link to activate your account. Complete the account activation by creating a password, and your account will become active. You can now securely send a message to OPAF through the platform.
If you encounter any issues or have questions during the application process, you can contact OPAF directly at 1-855-727-6274 between 8:00 AM and 8:00 PM ET. Their team is dedicated to assisting patients and ensuring they have a smooth experience when applying for support.
Verification and additional documentation
OPAF performs a benefit verification for insured patients. In some cases, the initial benefit verification may be insufficient, and OPAF may request additional denial documentation. This documentation can include an explanation of benefits, insurance statements, or prior authorization denial letters. Providing this information helps OPAF better understand your situation and determine the appropriate level of support they can offer.
OPAF offers no-cost support for a range of prescribed medications. It is crucial to consult the U.S. Full Prescribing Information or speak to your healthcare provider for each medication to understand its uses, dosage, and potential side effects. Currently, the supported medications are:
- NUEDEXTA: A medication indicated for the treatment of pseudobulbar affect (PBA)
- ABILIFY MAINTENA: A long-acting injectable medication used to manage schizophrenia and bipolar disorder
- ABILIFY ASIMTUFII: Another medication indicated for the treatment of schizophrenia and bipolar disorder
- JYNARQUE: A drug prescribed for the treatment of autosomal dominant polycystic kidney disease (ADPKD)
- REXULTI: A medication used to manage major depressive disorder and schizophrenia
- SAMSCA: A drug prescribed for the treatment of hyponatremia associated with certain conditions
Remember to review the full prescribing information and medication guides for a complete understanding of each medication, including any boxed warnings.
Reporting adverse reactions
If you experience any suspected adverse reactions while taking these medications, it is essential to report them promptly. Reach out to Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or contact the FDA at 1-800-FDA-1088. Your report can help ensure the safety and efficacy of these medications for all patients.
OPAF fund distribution
It’s important to note that Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation, Inc. distributes funds. OPAF operates independently to provide no-cost support to eligible patients. This independence ensures transparency and eliminates any potential conflicts of interest.
Prescription drug savings are within reach through programs like the Otsuka Patient Assistance Foundation. Supported medications, secure messaging for patient privacy, and the necessary documentation for eligibility have been discussed in this comprehensive guide. By leveraging these resources, eligible patients can access the prescribed medications they need without the financial burden. Don’t hesitate to reach out to OPAF for further assistance and support.
If you have any questions or need guidance throughout the process, please contact OPAF at 1-855-727-6274 between 8:00 AM and 8:00 PM ET. Start your journey to prescription drug savings today by activating your secure messaging account and taking advantage of the support provided by OPAF.
- It is important to note that eligibility criteria may vary, and it is advisable to consult OPAF directly for the most up-to-date information
- OPAF’s support is not limited to the mentioned medications. Please refer to their website or contact them for further details
- Otsuka Patient Assistance Foundation | No-Cost Treatment Support
- Check eligibility – Otsuka Patient Assistance Foundation
- OPAF Care Connect Patient Portal – Otsuka Patient Assistance Foundation
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information in this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
WHY WE BUILT NOWPATIENT
To improve the lives of everyone by making high-quality care accessible and convenient
We are here to improve lives. Our service gives you access to smart features and resources that can help empower you to take control of your health and improve your health outcomes. All this, in one place, for FREE. We strive to bring a fresh perspective to managing health. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Can I trust NowPatient
Meet our medical review team
Trustworthy and reliable medical content authored and reviewed by our experienced team of medical professionals from the United Kingdom and the United States. Learn more about our team and our editorial process by clicking on the buttons below.